# 65162-024-09 · Lisdexamfetamine Dimesylate Capsule · Amneal Pharmaceuticals — FDA drug shortage duration tracker For 65162-024-09 · Lisdexamfetamine Dimesylate Capsule · Amneal Pharmaceuticals, package ndc is 65162-024-09; generic name is Lisdexamfetamine Dimesylate Capsule; manufacturer is Amneal Pharmaceuticals; status is Current; availability now is Available, recorded from its source on 2026-09-01. - **Package NDC:** 65162-024-09 _(verified: appears in the quote below)_ - **Generic name:** Lisdexamfetamine Dimesylate Capsule _(verified: appears in the quote below)_ - **Manufacturer:** Amneal Pharmaceuticals _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **Initial posting date:** 07/14/2023 _(verified: appears in the quote below)_ - **Last update date:** 06/17/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1145 _(our reading, not quoted from the source)_ - **Dosage form:** Capsule _(verified: appears in its own passage below)_ - **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "07/14/2023", "package_ndc": "65162-024-09", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "866-525-7270", "availability": "Available" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "06/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current" ### Status > "update_date": "06/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current" ### Last update date > "update_date": "06/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current" ### Dosage form > "update_date": "06/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current" ### Therapeutic category > "update_date": "06/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-01. Review by: 2026-09-04. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).